Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Qiagen Stock Quote

Qiagen (NYSE: QGEN)

$39.47
(0.6%)
$0.24
Price as of April 18, 2024, 4:00 p.m. ET

Qiagen Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
QGEN -13.23% +2.97% +0.59% +1,988%
S&P +20.62% +72.50% +11.51% +647%

Qiagen Company Info

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

News & Analysis

The Fool has written over 100 articles on Qiagen.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.